Literature DB >> 31223668

On the Neuromodulatory Pathways of the In Vivo Brain by Means of Transcranial Focused Ultrasound.

Xiaodan Niu1, Kai Yu2, Bin He1.   

Abstract

For last decade, low-intensity transcranial focused ultrasound (tFUS) has been rapidly developed for a myriad of successful applications in neuromodulation. tFUS possesses high spatial resolution, focality and depth penetration as a noninvasive neuromodulation tool. Despite the promise, confounding activation can be observed in rodents when stimulation parameters are not selected carefully. Here we summarize the existing classes of observations for ultrasound neuromodulation: ultrasound directly activates a localized area, or ultrasound indirectly activates auditory pathways, which further propagates to other cortical networks. We also present control in vivo animal studies, which suggest that underlying tFUS brain modulation is characterized by localized activation independent of auditory networks activations.

Entities:  

Keywords:  brain stimulation; low-intensity focused ultrasound; neuromodulation; tFUS; transcranial focused ultrasound

Year:  2018        PMID: 31223668      PMCID: PMC6585998          DOI: 10.1016/j.cobme.2018.10.004

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  13 in total

1.  Systematic examination of low-intensity ultrasound parameters on human motor cortex excitability and behavior.

Authors:  Anton Fomenko; Kai-Hsiang Stanley Chen; Jean-François Nankoo; James Saravanamuttu; Yanqiu Wang; Mazen El-Baba; Xue Xia; Shakthi Sanjana Seerala; Kullervo Hynynen; Andres M Lozano; Robert Chen
Journal:  Elife       Date:  2020-11-25       Impact factor: 8.140

Review 2.  Ultrasound Technologies for Imaging and Modulating Neural Activity.

Authors:  Claire Rabut; Sangjin Yoo; Robert C Hurt; Zhiyang Jin; Hongyi Li; Hongsun Guo; Bill Ling; Mikhail G Shapiro
Journal:  Neuron       Date:  2020-10-14       Impact factor: 17.173

3.  Transcranial ultrasound neuromodulation induces neuronal correlation change in the rat somatosensory cortex.

Authors:  Sandhya Ramachandran; Xiaodan Niu; Kai Yu; Bin He
Journal:  J Neural Eng       Date:  2022-09-06       Impact factor: 5.043

4.  Neuromodulation Management of Chronic Neuropathic Pain in The Central Nervous system.

Authors:  Kai Yu; Xiaodan Niu; Bin He
Journal:  Adv Funct Mater       Date:  2020-06-10       Impact factor: 18.808

5.  Transcranial Focused Ultrasound Enhances Sensory Discrimination Capability through Somatosensory Cortical Excitation.

Authors:  Chang Liu; Kai Yu; Xiaodan Niu; Bin He
Journal:  Ultrasound Med Biol       Date:  2021-02-20       Impact factor: 2.998

6.  Design and Optimization of Ultrasound Phased Arrays for Large-Scale Ultrasound Neuromodulation.

Authors:  Sheikh Jawad Ilham; Zeinab Kashani; Mehdi Kiani
Journal:  IEEE Trans Biomed Circuits Syst       Date:  2022-02-17       Impact factor: 3.833

7.  Closed-Loop Transcranial Ultrasound Stimulation for Real-Time Non-invasive Neuromodulation in vivo.

Authors:  Huifang Yang; Yi Yuan; Xingran Wang; Xin Li
Journal:  Front Neurosci       Date:  2020-05-12       Impact factor: 4.677

8.  Noninvasive Ultrasound Stimulation of Ventral Tegmental Area Induces Reanimation from General Anaesthesia in Mice.

Authors:  Tianyuan Bian; Wen Meng; Meihong Qiu; Zhigang Zhong; Zhengrong Lin; Junjie Zou; Yibo Wang; Xiaowei Huang; Lisheng Xu; Tifei Yuan; Zhili Huang; Lili Niu; Long Meng; Hairong Zheng
Journal:  Research (Wash D C)       Date:  2021-04-12

9.  Non-invasive ultrasonic neuromodulation of neuronal excitability for treatment of epilepsy.

Authors:  Zhengrong Lin; Long Meng; Junjie Zou; Wei Zhou; Xiaowei Huang; Shan Xue; Tianyuan Bian; Tifei Yuan; Lili Niu; Yanwu Guo; Hairong Zheng
Journal:  Theranostics       Date:  2020-04-12       Impact factor: 11.556

10.  Therapeutic Potential of Ultrasound Neuromodulation in Decreasing Neuropathic Pain: Clinical and Experimental Evidence.

Authors:  Iván Pérez-Neri; Alberto González-Aguilar; Hugo Sandoval; Carlos Pineda; Camilo Ríos
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.